Boston Scientific won FDA approval for its AngioJet ZelanteDVT thrombectomy catheter designed for treatment of deep vein thrombosis in large peripheral veins. The device can deliver four times the sucking power of previous AngioJet catheters from the AngioJet Ultra Console, and so able to remove larger clots with more consistency.
The device is intended for pulling out thrombi out of veins at least 6 mm in diameter, but can also be used for infusion of thrombolytic and other agents into the vasculature.
Here’s an animation of the workings of the AngioJet ZelanteDVT:
Product page: AngioJet ZelanteDVT…
Source: Boston Scientific…